Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 801–900 of 978
The Challenge of Diabetes Mellitus in the Contemporary Percutaneous Coronary Intervention Era
Baber, U. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.10.027 · Cited by 3
“adults with DM meet care goals for glycemic control, blood pressure, and cholesterol lowering (13).”
BackgroundWang, Y., Ajjan, R., Freeman, A., Stewart, P. M., Galdo, F. D., & Tiganescu, A. (2021) · medRxiv · doi:10.1101/2021.06.30.21259754 · Cited by 3
“Since 1980, global rates of type 2 diabetes mellitus (T2DM) have more than quadrupled and the 61 majority of countries remain unlikely to attain United Nation targets (3, 4).”
BackgroundOsei, E. P., Ekpor, E., Akyirem, S., Olanrewaju, F., Osei, G. Y., Kusi, V. B., Adawudu, E. A., Boahen, D. A., & Boakye, M. D. S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113452 · Cited by 2
Periodontitis and Diabetes Mellitus: A Complex Relationship
RYAN, M. E., Raja, V., & Sussman, S. K. (2016) · Springer eBooks · doi:10.1007/978-3-662-49699-2_3 · Cited by 3
Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus: A Cardiologist’s View
Bezdenezhnykh, N. A., Nikolaevich, S. A., Викторович, Б. А., & Leonidovna, B. O. (2017) · InTech eBooks · doi:10.5772/intechopen.70416 · Cited by 2
“3% of adult Americans with type 2 diabetes have target levels of HbA1c, blood pressure, and low-density lipoprotein cholesterol (LDL-C) [73].”
BackgroundInfluentialHeinrich, N. S., Kriegbaum, M., Grand, M. K., Lind, B., Andersen, C. L., & Persson, F. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.10.006 · Cited by 2
Diabetes: A Primary Health Care Approach
Zeytinoglu, M., & Huang, E. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-22357-5_10 · Cited by 2
Age and Age-old Disparities in Diabetes Care Persist
Ali, M. K., & Shah, M. K. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2392 · Cited by 2
Self-citationSawczyn, T., Stygar, D. M., Nabrdalik, K., Kukla, M., Masri, O., Magrowski, Ł., Karcz, W. K., & Jochem, J. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6699923 · Cited by 2
Diagnostic Criteria and Classification of Diabetes
Gospin, R., & Zonszein, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_7-1 · Cited by 2
Taye, M., Kotiso, K. S., Efrem, P., & Tarekegn, G. (2022) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v32i3.15 · Cited by 2
“8) years and the median duration (IQR) of diabetes was 12 (7, 20) years.”
BackgroundInfluentialMalik, A. O., Chen, H., Tang, F., Chan, P. S., Cooper, A., Gomes, M. B., Hejjaji, V., Ji, L., Khunti, K., Kosiborod, M., et al. (2022) · Indian Heart Journal · doi:10.1016/j.ihj.2022.07.008 · Cited by 2
Compliance of medical practitioners with diabetic treatment guidelines in West Rand, Gauteng
Ohanson, N. J., & Pretorius, D. (2023) · South African Family Practice · doi:10.4102/safp.v65i1.5633 · Cited by 2
Zhang, D., Gao, H., Song, X., Raposeiras‐Roubín, S., Abu‐Assi, E., Henriques, J. P. S., D’Ascenzo, F., Saucedo, J., González‐Juanatey, J. R., Wilton, S. B., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110833 · Cited by 2
Diabetes and Aging: Meeting the Needs of a Burgeoning Epidemic in the United States
Zeytinoglu, M., & Huang, E. S. (2015) · Health Systems & Reform · doi:10.1080/23288604.2015.1037042 · Cited by 3
Diabetes Prevention and Management: The Thrill Is Not Gone
Albright, A. L. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.1.63 · Cited by 2
The role of hormonal treatment in type 2 diabetes mellitus
Imam, S. K. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s49625 · Cited by 3
“Vast majorities of T2DM patients do not achieve the target glycemic control, and only one third of them meet the targets for good glycemic control, optimum blood pressure, and cholesterol control.(5) It is evident from the Diabetes Complications and Control Trial (DCCT) and the Epidemiology of Diabetes Interventions a…”
Ambery, P., Stylianou, A., Atkinson, G. F., Dott, C., Curtis, L. D., Haque, N., LaCroix, K. A. K., Min, K. W., & on behalf of the Glimepiride/Atorvastatin Investigational Team (2015) · Diabetic Medicine · doi:10.1111/dme.13003 · Cited by 3
Strotmeyer, E. S., & Zgibor, J. C. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.10.001 · Cited by 3
Shiga, T., Yokokawa, H., Taneda, Y., Sugihara, E., Meijyo, M., Mitsuhashi, K., Hisaoka, T., & Isonuma, H. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0049-4 · Cited by 2
“0% may be acceptable if lower targets cannot be achieved [6].”
BackgroundMehta, S. N., Goldfine, A. B., Abrahamson, M. J., McMullen, W., & Laffel, L. M. (2016) · Endocrine Practice · doi:10.4158/ep151080.or · Cited by 2
“Since 1988, the proportion of patients with ABC control in the general population has risen (21,23,24).”
BackgroundAffordable Care Act Implementation: Challenges and Opportunities to Impact Patients With Diabetes
Powers, A. C., Wexler, J. A., Lash, R. W., Dyer, M. C., Becker, M. N., & Vigersky, R. A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1047 · Cited by 2
All-Cause Mortality for Diabetics or Individuals with Hyperglycemia Applying for Life Insurance
Freitas, S. A., MacKenzie, R., Wylde, D. N., Roudebush, B. T., Bergstrom, R. L., Holowaty, J. C., Hart, A., Rigatti, S. J., & Gill, S. (2016) · Journal of Insurance Medicine · doi:10.17849/0743-6661-46.1.2 · Cited by 2
“Diabetes increases the risk of disabling and life-threatening complications from micro‐ vascular disease (affecting the kidneys, eyes and limbs) andmacro-vascular disease (involv‐ ing the coronary vascular, cerebrovascular, and peripheral vascular systems).(3) As a result, mortality rates are significantly higher in i…”
BackgroundKawazu, S., Kanazawa, Y., Iwamoto, Y., Katayama, S., Origasa, H., & Kuzuya, T. (2017) · Diabetology International · doi:10.1007/s13340-017-0319-x · Cited by 2
Pereira, C. A., Almeida, R., & Dores, J. M. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.150 · Cited by 2
Luk, A. O. Y., Kong, A. P. S., & Basu, A. (2020) · Diabetic Medicine · doi:10.1111/dme.14335 · Cited by 2
Varadarajan, A., Walker, R. J., Williams, J. S., Bishu, K. G., Nagavally, S., & Egede, L. E. (2020) · International Journal of Health Governance · doi:10.1108/ijhg-02-2020-0014 · Cited by 2
Type 2 Diabetes Mellitus (T2DM) in the Arab Society of Israel
Zalan, A. A., & Sharkia, R. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-36811-1_162 · Cited by 2
Dietary Therapy of Diabetes Mellitus
Ebel, F. E., Strain, G. W., & Doyle, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_41-3 · Cited by 2
End-Stage Kidney Failure in the Diabetic Patient
Williams, M. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79135-9.00049-5 · Cited by 2
Teti, A., Gabrys, L., Ziese, T., Scheidt‐Nave, C., Heidemann, C., Gabrys, L., Schmidt, C., Teti, A., Wolf, I.-K., Du, Y., et al. (2017) · BMC Proceedings · doi:10.1186/s12919-016-0070-5 · Cited by 8
Self-citationAddressing Noncommunicable Diseases in Primary Care: The Case of Type 2 Diabetes
Narayan, K. M. V., & Rhodes, E. (2016) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2016.414 · Cited by 3
SGLT2 Inhibitors Therapy in Type 2 Diabetes Mellitus
Ahmad, M. M., Brema, I. A., & Almalki, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84152 · Cited by 3
Reducing the Burden of Diabetes Mellitus in the State of Missouri: A Call to Action.
Drees, B. M., & Yun, S. (2016) · Europe PMC (PubMed Central) · Cited by 2
Tabingo, N., & Verzone, A. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.04.008 · Cited by 3
Diagnostic Criteria and Classification of Diabetes
Gospin, R., Leu, J. P., & Zonszein, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_7 · Cited by 7
Medical Screening/Assessment in the Dental Office
Greenberg, B. L., & Glick, M. (2015) · Wiley eBooks · doi:10.1002/9781119121039.ch21 · Cited by 3
Rodríguez‐Saldaña, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_1 · Cited by 3
Carlos Zavala, U., & Fernando Florenzano, U. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.04.006 · Cited by 6
Detection of Liaison Between Health Outcome and Web Search
Roy, S., & Saha, A. K. (2019) · Advances in intelligent systems and computing · doi:10.1007/978-981-13-7166-0_38 · Cited by 1
Sharma, S., Tripathi, C. B., Annapoorna, K., Dhond, S. S., Sharma, D., Srivastava, J. P., & Kotwal, A. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13670-0 · Cited by 1
“When applied rigorously, STGs improve outcomes in heart disease [21] and diabetes [22], while reducing costs and optimizing resource use [23].”
Rajale, P., Meshram, N., Vinchurkar, K., & Borse, L. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02206-6 · Cited by 3
Hariyani, P. H. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20261691 · Cited by 1
Narayan, K. M. V. (2026) · Diabetes Care · doi:10.2337/dci25-0116 · Cited by 1
Gaid, D., Giasson, G., Gaboury, I., Houle, L., Layani, G., Menear, M., de Tilly, V. N., Pomey, M., & Vachon, B. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02641-9 · Cited by 3
Mishra, S. R., Marschner, S. L., Min, H., Mahendran, S., Thiagalingam, A., Poulter, R. S., Redfern, J., Brieger, D. B., Thompson, P. L., Hillis, G. S., et al. (2026) · Open Heart · doi:10.1136/openhrt-2025-003856 · Cited by 1
Freeman, J. S. (2013) · Drugs in Context · doi:10.7573/dic.212256 · Cited by 1
Esposito, K., Maiorino, M. I., Bellastella, G., & Giugliano, D. (2014) · Cited by 1
Diabetische Retinopathie und Neuropathie: Neuigkeiten 2015
Henzen, C. (2015) · Praxis · doi:10.1024/1661-8157/a002024 · Cited by 2
“Ein Grund für diese Entwicklung liegt darin, dass rund die Hälfte der Diabetiker die in Guidelines definierten BehandlungsZielwerte für HbA1c, Blutdruck und Lipide nicht erreichen und im Weiteren von den wichtigen präventiven Massnahmen nicht profitieren können: So haben die US-amerikanischen NHANES-Daten von 1999 zu…”
BackgroundGlucose, cholesterol, and blood pressure: is lower always better for type 2 diabetes?
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2016) · Endocrine · doi:10.1007/s12020-016-0981-y · Cited by 2
Surgical or medical therapy for patients with obesity and T2DM?
Madsbad, S., & Holst, J. J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.111 · Cited by 1
The upside down world of diabetes care medical economics and what we might do to improve it
Harlan, D. M., & Hirsch, I. B. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000325 · Cited by 2
“Good data supports well accepted treatment goals for glycaemia, blood pressure, lipids, tobacco cessation, vaccinations, retinal screening, and so on and yet only a small minority of those with diabetes meet those treatment goals [3].”
BackgroundBezdenezhnykh, N. A., Sumin, A. N., & Барбараш, О. Л. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-5-146-152 · Cited by 1
Huggins, G. S., Berger, S. E., & McCaffery, J. M. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0464-3 · Cited by 1
Nanobased scientific and technological solutions for the management of diabetes mellitus
Picu, A. A., Petcu, L. M., & Chifiriuc, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816506-5.00014-0 · Cited by 1
Khan, F. N., Shaikh, N. I., Narayan, K. M. V., & Ali, M. K. (2021) · doi:10.1093/med/9780198816805.003.0064 · Cited by 1
Self-citationInternal Medicine Resident Adherence to Evidence-Based Practices in Management of Diabetes Mellitus
Mehta, C., Cohen, D., Jaisinghani, P., & Parikh, P. D. (2022) · Journal of Medical Education and Curricular Development · doi:10.1177/23821205221076659 · Cited by 2
“edge, or (3) there may have been intrinsic differences between residency groups that disallow appropriate comparisons.”
BackgroundAnsari, N. E., Chadli, A., Aziz, S. E., Mghari, G. E., Achhab, Y. E., Seqat, M., & Nejjari, C. (2015) · Journal of Endocrinology and Metabolism · doi:10.14740/jem314w · Cited by 1
Dietary Therapy of Diabetes Mellitus
Ebel, F. E., Strain, G. W., & Doyle, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_41 · Cited by 1
Prato, S. D., & Raz, I. (2013) · Diabetes Care · doi:10.2337/dcs13-2046 · Cited by 1
“adults with diabetes do not meet the recommended goals for diabetes care including HbA1c, lipid, and blood pressure levels (5).”
BackgroundUse of Automated Bolus Calculators for Diabetes Management
Schwartz, F., & Marling, C. R. (2013) · US Endocrinology · doi:10.17925/use.2013.09.02.124 · Cited by 1
Chapter 4: Nutrition Therapy: Healthy Eating and Regular Physical Activity
Franz, M. J., & Daly, A. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.04 · Cited by 1
Rodríguez, P. V., Mastroianni, P. D. C., Samaniego, L. R., Lugo, G. B., Maciel, O. Y., & Maidana, G. M. (2023) · Pharmaceutical care España · doi:10.60103/phc.v25i4.815 · Cited by 1
Singh, R. K., Singh, K. K., Singh, A., Khan, I. A., & Yadav, S. C. (2023) · Cureus · doi:10.7759/cureus.46904 · Cited by 1
“Similarly, suboptimal glycemic control was also found in patients with T2DM in studies conducted in the past [16,17].”
BackgroundGarza‐Ocañas, L., Badillo-Castañeda, C. T., Montoya-Eguía, S. L., Zanatta-Calderón, M. T., Sáenz‐Chávez, P. L., Torres‐Garza, J. D., Rodríguez-Vázquez, I. C., Romero‐Antonio, Y., RIOS-BRITO, K. F., & González‐Canudas, J. (2024) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1450 · Cited by 1
Sayed, A., Labieb, F., Stevens, E. R., Tamura, K., Boakye, E., Virani, S. S., Jiang, N., Hu, L., Blaha, M. J., & Shahawy, O. E. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108085 · Cited by 1
Khalili, L. E., Khalili, L. E., Rawshani, A., Borén, J., Bhatt, D. L., Gerstein, H. C., McGuire, D. K., Helleryd, E., Ömerovic, E., Eliasson, B., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02561-z · Cited by 1
“The non-significant excess risk can be due to improved management and treatment of cardiometabolic risk factors [13–15] such as HbA1c, blood pressure, lipid levels, and reduced smoking within the population.”
Giugliano, D., Longo, M., Caruso, P., Scappaticcio, L., Pontillo, A., Martino, N. D., Porcellini, C., Angelino, S., Caputo, M., Bellastella, G., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06535-y · Cited by 1
“To the Editor: Many individuals with type 2 diabetes do not achieve adequate lowering of HbA 1c , even when using complex insulin regimens [1].”
Cetoacidosis diabética en niños: experiencia hospitalaria. Estudio retrospectivo de 15 años
Rivera, N. G., Zárate, M. G. G., Chon, I. F., Figueroa, C. O. G., Jiménez, I. A. G., & García, L. V. (2015) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2015.09.002 · Cited by 4
Saundankar, V., Ellis, J. J., Moretz, C., MEAH, Y. A., DeLuzio, T., Allen, E., Suehs, B. T., & Bouchard, J. R. (2016) · Population Health Management · doi:10.1089/pop.2015.0159 · Cited by 1
“DM was one of the first diseases included in the quality measures (QMs) because of the prevalence of DM in the US population and the measurable parameters related to this disease.(4) The impact of DM in the United States is considerable and expands yearly, negatively influencing patient well-being and health care spen…”
Efectividad del Decálogo de prevención cardiovascular en diabéticos
Carpio, A. O., Álvaro, M. M., Vidarte, A. D., Ruiz, C., Gonzalez-Ripoll, C. C., & Herráiz, F. R. (2018) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2018.01.013 · Cited by 1
Type 2 Diabetes Mellitus (T2DM) in the Arab Society of Israel
Zalan, A. A., & Sharkia, R. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-74365-3_162-1 · Cited by 1
Diabetes Management in the United States
Ali, M. K., Shah, M. K., & Moin, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_17 · Cited by 1
Self-citationLinari, M. A., González, C. D., Dieuzeide, G., Badia, M. F., Argerich, M. I., Echenique, M. S., Frechtel, G. D., Álvaro, O., Babus, M. D. C., Botta, D., et al. (2019) · Alad · doi:10.24875/alad.19000378 · Cited by 1
Patient Education As an Independent Treatment Factor of Type 2 Diabetes Management
Матюха, Л. Ф., & Смаль, Б. О. (2019) · Family Medicine · doi:10.30841/2307-5112.3.2019.178573 · Cited by 2
Nghiên cứu tình trạng kiểm soát glucose máu và các yếu tố ảnh hưởng trên bệnh nhân đái tháo đường
Trần, T. T., Đặng, T. L., & Nguyễn, V. B. (2021) · Vietnam Journal of Diabetes and Endocrinology · doi:10.47122/vjde.2020.41.7 · Cited by 1
Kanatsuka, A., Sato, Y., Higashi, Y., Goto, Y., Kawai, K., Maegawa, H., & Japan Diabetes Data Management Study Group (JDDM) (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13558 · Cited by 1
Assessment of Glycemic Control at St. Luke’s Free Medical Clinic: Retrospective Chart Review
Hopper, W. A., Fox, J., & DiMucci-Ward, J. (2021) · Interactive Journal of Medical Research · doi:10.2196/31123 · Cited by 1
“Rates of control at the SLFMC were within 10% of two recent NHANES samples reported by Ali et al and Carls et al [31,32].”
ResultMedical Practice Variations in Diabetes Mellitus
Gamble, J., & Butalia, S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7573-7_85-1 · Cited by 1
Romeo, G. R., Silva, P. S., & Cavallerano, J. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_294 · Cited by 1
Inhalation of Insulin for Diabetes Management
Bahman, F., & Taurin, S. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165498-00165 · Cited by 1
Diabetes Management in the United States
Shah, M. K., Khan, F. N., & Ali, M. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_19 · Cited by 1
Self-citationAn Observational Study to Assess the Predictors of Cardiac Dysfunction in Type 2 Diabetes Patients
Chauhan, M. (2023) · Journal of Advanced Research in Medicine · doi:10.24321/2349.7181.202302 · Cited by 1
Aguiar, P. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2014.tde-11122014-153048 · Cited by 2
Taetzsch, A. (2014) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/thesis-taetzsch-amy-2014 · Cited by 1
Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy
Zonszein, J., & Brownlee, M. (2018) · Annals of Internal Medicine · doi:10.7326/l18-0372 · Cited by 1
Aguirre-Duarte, N., Carswell, P., & Kenealy, T. W. (2020) · medRxiv · doi:10.1101/2020.04.07.20057380 · Cited by 1
“There is a vast amount of clinical evidence suggesting the benefits of the glycaemic control (6, 7), however more than 40% of these patients struggle to reach those targets (8, 9).”
BackgroundLiu, H., Wang, F., Li, Y., Xia, H., Pan, D., Yang, L., Wang, S., & Sun, G. (2020) · Preprints.org · doi:10.20944/preprints202010.0563.v1 · Cited by 1
“8% of patients with T2DM have healthy blood lipid levels [6].”
BackgroundFang, C., Qi, X., Yuan, T., Zhu, Z., Li, J., Zhang, Q., Jia, J., & Sun, J. (2025) · Research Square · doi:10.21203/rs.3.rs-5704576/v1 · Cited by 1
Lithovius, R. (2015) · Helda - University of Helsinki Institutional Repository
Excoffier, S., Blum, M. R., Rodondi, N., Cornuz, J., Zimmerli, L., Gaspoz, J., & Guessous, I. (2015) · Open Journal of Preventive Medicine · doi:10.4236/ojpm.2015.56028
“8% [13].”
Correspondence: Response to Letter to the Editor by K Scharf and J Morton
Lebovitz, H. E. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1099-4
“Actually, medical therapy for many patients with type 2 diabetes achieves target levels of HbA1C, LDL cholesterol, and blood pressure [1], and evenmore importantly, the rates of vascular complications from diabetes have fallen approximately 30 to 40 % in recent years [2].”
Lewis, K. H., & Arterburn, D. E. (2013) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2013-101580
Meece, J. D., Pearson, T. L., & Siminerio, L. M. (2014) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721714527802
“Modifiable risk factors for diabetes include being overweight or obese,(33) and unfortunately, current data suggest that 87% of persons living with diabetes in the United States are not at a healthy weight (Figure 5).(35)”
BackgroundInternet Diabetes Management: A Practical Approach
Tildesley, H. D., Chow, N., White, A. S., Pawłowska, M., & Ross, S. A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.12.005 · Cited by 1
RetractedLiao, E. P., & Poretsky, L. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.006
The Problem of Diabetes and Cardiovascular Disease: Include Women in the Solution
Witt, D., Boucher, J. L., & Hayes, S. N. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.3.139 · Cited by 1
Becker, A. D., de Lima, E. D. S., Ledur, P. D. S., & Schaan, B. D. (2014) · Americanae (AECID Library)
Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007–2012
Bullard, K. M., Ali, M. K., Imperatore, G., Geiss, L. S., Saydah, S., Albu, J., Cowie, C. C., Sohler, N., Albright, A., & Gregg, E. W. (2015) · PLoS ONE · doi:10.7916/d8pn95dn
Self-citationNascimento, T. M. R. D. V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-12042016-144245
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.